Spotlight on molecular profiling: “Integromic” analysis of the NCI-60 cancer cell lines
Open Access
- 1 November 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (11) , 2601-2605
- https://doi.org/10.1158/1535-7163.mct-06-0640
Abstract
“Our horizon is never quite at our elbows” –Henry David Thoreau, Walden (1854) In this issue, Molecular Cancer Therapeutics launches a brave new experiment in the publication of pharmacogenomic and pharmacoproteomic information: a series of invited, refereed articles justified by the broadThis publication has 21 references indexed in Scilit:
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in CancerCancer Research, 2006
- Molecular Interaction Maps of Bioregulatory Networks: A General Rubric for Systems BiologyMolecular Biology of the Cell, 2006
- Update on NCI in vitro drug screen utilitiesEuropean Journal Of Cancer, 2004
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Fishing ExpeditionsScience, 1998
- A protein expression database for the molecular pharmacology of cancerElectrophoresis, 1997
- Use of the Kohonen Self-organizing Map to Study the Mechanisms of Action of Chemotherapeutic AgentsJNCI Journal of the National Cancer Institute, 1994
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI Journal of the National Cancer Institute, 1989